BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 36061875)

  • 1. Relationship between
    Xu W; Xu L; Xu C
    Front Cell Infect Microbiol; 2022; 12():938608. PubMed ID: 36061875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helicobacter pylori and non-malignant upper gastrointestinal diseases.
    Vasapolli R; Malfertheiner P; Kandulski A
    Helicobacter; 2016 Sep; 21 Suppl 1():30-3. PubMed ID: 27531536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease.
    Voutilainen M; Mäntynen T; Färkkilä M; Juhola M; Sipponen P
    Scand J Gastroenterol; 2001 Aug; 36(8):817-21. PubMed ID: 11495076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategy for treatment of Helicobacter pylori infection in adults. I. Updated indications for test and eradication therapy suggested in 2000.
    Nakajima S; Graham DY; Hattori T; Bamba T
    Curr Pharm Des; 2000 Oct; 6(15):1503-14. PubMed ID: 10974147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-line treatment of Helicobacter pylori in Lebanon: Comparison of bismuth-containing quadruple therapy versus 14-days sequential therapy.
    Tarhini M; Fayyad-Kazan M; Fayyad-Kazan H; Mokbel M; Nasreddine M; Badran B; Kchour G
    Microb Pathog; 2018 Apr; 117():23-26. PubMed ID: 29428426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori infection and nonmalignant diseases.
    Sjomina O; Heluwaert F; Moussata D; Leja M
    Helicobacter; 2017 Sep; 22 Suppl 1():. PubMed ID: 28891136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Eradication of Helicobacter pylori. Is it necessary to eradicate Helicobacter pylori in gastric reflux?].
    de Korwin JD
    Presse Med; 2001 Sep; 30(26):1313-20. PubMed ID: 11603095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CagA status and Helicobacter pylori eradication among dyspeptic patients.
    Magalhães AF; Carvalhaes A; Natan-Eisig J; Paraíso-Ferraz JG; Trevisan M; Zaterkaad S
    Gastroenterol Hepatol; 2005 Oct; 28(8):441-4. PubMed ID: 16185577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in plasma ghrelin and leptin levels in patients with peptic ulcer and gastritis following eradication of Helicobacter pylori infection.
    Kasai C; Sugimoto K; Moritani I; Tanaka J; Oya Y; Inoue H; Tameda M; Shiraki K; Ito M; Takei Y; Takase K
    BMC Gastroenterol; 2016 Oct; 16(1):119. PubMed ID: 27716077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori and nonmalignant upper gastrointestinal diseases.
    Jonaitis L; Pellicano R; Kupcinskas L
    Helicobacter; 2018 Sep; 23 Suppl 1():e12522. PubMed ID: 30203583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of Helicobacter pylori infection in dyspeptic patients in Libya.
    Bakka AS; El-Gariani AB; AbouGhrara FM; Salih BA
    Saudi Med J; 2002 Oct; 23(10):1261-5. PubMed ID: 12436134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Progress in the treatment of Helicobacter pylori infection].
    Tu S; Yang H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Sep; 39(9):981-8. PubMed ID: 25269503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Good bugs and bad bugs: indications and therapies for Helicobacter pylori eradication.
    Kuipers EJ; Janssen MJ; de Boer WA
    Curr Opin Pharmacol; 2003 Oct; 3(5):480-5. PubMed ID: 14559092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease trends after
    Mizukami K; Sugano K; Takeshima T; Murakami K
    World J Gastroenterol; 2023 Jan; 29(4):692-705. PubMed ID: 36742170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Helicobacter pylori eradication. Therapeutic evolution, value of complementary studies].
    Bigard MA
    Presse Med; 2001 Sep; 30(26):1305-12. PubMed ID: 11603094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori and Nonmalignant Diseases.
    Potamitis GS; Axon AT
    Helicobacter; 2015 Sep; 20 Suppl 1():26-9. PubMed ID: 26372821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term consequences of Helicobacter pylori eradication.
    Tytgat GN
    Scand J Gastroenterol Suppl; 1994; 205():38-44. PubMed ID: 7863240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori and gastroesophageal reflux disease: friends or foes?
    Gisbert JP; Pajares JM; Losa C
    Hepatogastroenterology; 1999; 46(26):1023-9. PubMed ID: 10370661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
    Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
    Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of Helicobacter pylori infection: current status].
    Wagner S; Gebel M; Manns M
    Z Gastroenterol; 1993; 31(7-8):459-63. PubMed ID: 8379235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.